Adriamycin - efficacy and possible adverse effects
Adriamycin (doxorubicin) is a chemical substance in the anthracycline class with a wide range of applications in oncology and hematology. The mechanism of action of Adriamycin is related to formation of irregular bonds between nucleobases of DNA and inhibition of key enzymes of DNA synthesis - topoi...
Main Authors: | Pedrycz Agnieszka, Kramkowska Agnieszka |
---|---|
Format: | Article |
Language: | deu |
Published: |
Sciendo
2016-03-01
|
Series: | Current Problems of Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1515/cpp-2016-0006 |
Similar Items
-
Investigation of The Effects of Pleurotus Eryngii Extract on Adriamycin-İnduced Cardiotoxicity in Sprague-Dawley Rats
by: Elif Erdem Güzel
Published: (2021-06-01) -
p-Coumaric acid alleviates adriamycin-induced hepatotoxicity in rats
by: Zeinab Rafiee, et al.
Published: (2021-01-01) -
The efficacy and safety of the targeted drug combined with adriamycin liposome solution for HER-2-positive breast cancer
by: Zi-Ping Zhou, et al.
Published: (2017-05-01) -
Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review
by: Azar Hosseini, et al.
Published: (2017-12-01) -
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020-02-01)